We attempted to determine if women younger than 45 years ofage who have isolated papillary thyroid cancer and whose tumors are smaller than 4 cm (T2NOMO) are at low risk f or mortality and morb idity f ollowing thyroid lobectomy. To this end, we analyzed information on both women and men obtained f rom our review of the literature, and we integrated it with data compiled in the Delaware Cancer Registry. We performed a secondary analysis to determine ifthe risk ofdeath and recurrence can be predicted on the basis of age, tumor size, sex, histology, and the type ofoperation. Wefound that among patients who had undergone either thyroid lobectomy or total thyroidectomy, mortality rates were l.3%for those younger than 45 years of age and 15.6%for those 45 years and older(p<O.OOOl). With respec t to tumor size, patients whose masses were smaller than 4 em had significantly lower mortality (3.0%) and recurrence (11.1%) rates than did those whose tumors were 4 em or larger (16.8 and 33.3%, respectively; p<O.OOOl). Other significant risk f actors f or death were male sex and the presence of f ollicular thyroid cancer (as oppose d to papillary thyroid cancer). The risk of permanent hypocalcemia was significant among pati ents who had undergone total thyroidectomy, but not among those who had been treated with lobectomy. The subgroup ofpatients who had the lowest risk of mortality and morbidity was made up of women younger than 45 years who had a papillary thyroid tumor smaller than 4 em that was limited to one lobe and who had undergone lobectomy. On the other hand, we fou nd that lobectomy might carry a higher risk of recurrence (from a micrometastasis in the cervica l lymph node) than 856 does total thyroidectomy. Experienced surgeons whose rates of hypocalcemia and recurrent laryngeal nerve paralysis foll owing total thyroidectomy are low offer their patients the unambiguous advantage of superior f ollow-up with thyroglobulin and radioactive iodine.
Introduction
Total thyroidectomy for papillary and follicular thyroid cancer is recommended for patient s who are 45 years or older and for tho se who have large tumors , bilateral disease, and cervical or distant met astasis or other extrathyroidal spread. Conversely, few surgeons would argue that thyroid lobectomy is appropriate for patients younger than 45 years who have a tumor smaller than 1cm (Tl NOMO) that is limited clinically to one lobe. We set out to determine whether women younger than 45 years who have a papillary thyroid cancer smaller than 4 em (T2NOMO) can be treated with thyroid lobectomy and experience low mortality and morbidity rates.
No prospective, randomized study has compared survival after total thyroidectomy, subtotal thyroidectomy, and thyroid lobectomy. Such an investigation would require decade s of study and data accumulation. Becau se thyroid cancer deaths can occur decades after diagnosis, follow-up period s of 15 to 25 years are often necessary.1. 2 In conducting our study, we integrated data compiled in the Delaware Cancer Registry with information obtained through our own historical literature review. We analyzed mortality and recurrence rates as a function of age, tumor size, sex, histology, and the type of operation. We also determined the incidence of hypocalcemia and recurrent laryngeal nerve dysfunction according to the type of operation.
The literature is made up of widely divergent types of reports.v' Narrative literature reviews describe series of studies, all of which have their particular strengths and weaknesses, that are discussed selectively and inform ally by one or more expert s. A prima ry analysis contains original data, and a secondary analysis-such as the one we performed-contains a re-examination of previously published data. A meta-analysis is a statistical study of a collection of data obtained from many individual studies. Meta-analyses and quantitative retrospective analyses emphasize numbers over narrative, and they have greater statistical power than do other types of studies. Although meta-analyses are most useful when they include randomized , controlled trials, they have been used selectively in the otolaryngology literature to evaluate retrospective studies.'
Authors of numerous articles on differentiated thyroid cancer that appear in the endocrine and general surgery literature have advocated the use of total thyroidectomy, subtotal thyroidectomy, or lobectomy, depending on patient characteristics that predict survival and recurrence. However, the myriad classification systems in use make cross-comparisons difficult. In conducting searches of several databases covering the period from 1966 through 1998, we failed to find any meta-analysis or historical literature review that included data on all eight selected aspects of differentiated thyroid cancer that we wished to study ; these eight aspects are mortality, recurrence, complications, age, tumor size , sex, histology, and type of operation. ' In this article, we report our analysis of data obtained from published articles in which the authors advocated lobectomy (defined as lobectomy or thyroid isthmusectomy), subtotal thyroidectomy, or total thyroidectomy (either-total or near-total) for differentiated thyroid carcinoma as well as data obtained from articles in which the authors took no stance on a preferred treatment. Discussions of prognostic factors and their influence on the management of differentiated thyroid cancer are sparse in the otolaryngology-head and neck surgery literature. Our analysis is unique in that no other article on prognostic factors in differentiated thyroid cancer included integrated data sets obtained from multiple studies and a state cancer registry.
Materials and methods
We conducted a MEDLINE search for English-language articles dealing with differentiated thyroid cancer that had been published from 1966 through 1998. We also performed manual cross-checks, including perusal of articles listed in textbook bibliographies, in symposium publications, in Current Contents, and in review articles. Finally, we searched MEDLINE, HealthStar, CINAHL (Cumulative Index to Nursing and Allied Health Literature), CancerLit, and Current Contents from 1966 through 1998 using thyroid neoplasm and meta-analysis as controlled vocabulary, and we did not find any systematic review of prognostic factors in differentiated thyroid neoplasms.
In all, we reviewed abstracts of 231 articles. Inclusion Volume 81, Number 12 criteria included retrospective studies (no prospective studies exist) on death, recurrence, and morbidity in differentiated thyroid cancer. We excluded studies that contained data from a single institution that had already been published in another article (and, therefore, had already been accounted for) and studies in which data were presented only in graph form, making extraction of actual whole numbers impossible. All usable data were extracted by the primary author (R.L.W.) and a research assistant (A.M .M.); we relied on interobserver agreement to reduce error and achieve consistency. We ultimately reviewed data contained in the "Materials" sections of 56 studies, and from these we selected 19 studiess" for our analysis. The selection of these 19 studies was not based on results , country of origin, or the type of operation advocated, if any. Nine of these studies were from North America, five from Asia, four from Europe, and one from Israel. For the treatment of selected differentiated thyroid carcinomas, thyroid lobectomy was favored in eight studies,6. Nine studies contained information on the mean length of follow-up (mean : 12.4 yr), six specified only a range of follow-up, and four did not mention the length of followup. The average publication date of those studies in which lobectomy was advocated was 1988, and the average date of those in which total thyroidectomy was favored was 1992. Our historical literature review was performed to examine the rates of death and recurrence in patients with differentiated thyroid tumors and to compare outcomes according to five parameters: (1) patients younger than 45 years vs patients 45 years and older, (2) tumors smaller than 4 em vs tumors 4 em and larger, (3) men vs women, (4) papillary vs follicular histology, and (5) thyroid lobectomy and subtotal thyroidectomy vs total thyroidectomy. We also made a three-way comparison of the incidence of permanent hypocalcemia and recurrent laryngeal nerve dysfunction in patients who had undergone lobectomy, subtotal thyroidectomy, and total thyroidectomy.
We also reviewed data published by Brierley et al," who studied 10 different staging systems for predicting outcomes and found that none was significantly superior to the TNM classification system used by the American Joint Committee on Cancer and the International Union Against Cancer. Also , several studies have suggested that W ID, MCNAMARA age is the single mos t impor tant variab le for survival.17.22 Therefore, we selected age and tumor size as study parameters . We handled variations in others' reporting of age and .tumor size in two ways : (I) when sources classified patients as either younger or older than 50 years, we excluded from our analy sis all those who were younger ;
(2) when sources categorize d tumor sizes as either smaller or larger than 5 em, we excluded all that were smaller.
Finally, we conduct ed a retrospective review of data compiled fro m 1988 through 1997 in the Delaware Cancer Registry and integrated them into our quantitative retrospective literature analysis. Two independent biostatisticia ns reviewed our data.
Res u lts
Age. The mortality rate among patients younger than 45 years who had either papi llary or follicular thyroid carcinoma (regardless of tumor size) was 1.3%; the rate for patients 45 years and older was 15.6%-a statistically significant difference (p<0.0001) (table 1). Recurrence rates in the two age group s were not significantly different.
Tumor size. Among patients whose tumors were smaller than 4 em (regardless of age), the mortality rate was 3.0% and the recurrence rate was 11.1% (table 2). Among those whose tumors were 4 em or larger, the corresponding rates were 16.8 and 33.3%. The differences in both mortality and recurrence rates between the two groups were statistically significant (p<0.000 1).
Sex. Female sex was a significant factor in a lower risk of death (mortality: 5.6% among women and 8.4% among men; p = 0.01), but not in recurrence (table 3) .
Histology . Patients with papillary thyroid cancer had a significantly lower mortality rate than did those with follicularcancer-4.4 and 12.7%, respectively (p<0.0001) (table 4). However, those who had follicular cancer had a significantly lower rate of recurrence-6.4 and 12.9%, respectively (p = 0.02).
Type of operation. Regardless of age and tumor size, the mortality rate among patients who had undergone total thyroidectomy (4.7%) was significantly lower Table 3 . Mortality and recurrence according to sex (p = 0.002) than the combined rate among those who had undergone either subtotal thyroidectomy or lobectomy (8.1%) (table 5). There was no significant difference between the two groups with respect to recurrence rates.
Hypocalc emia. The rates of permanent hypocalcemi a were 6.4% following total thyroidectomy (during the 1990s), 1.9% followi ng subtotal thyroidectomy, and 0% following lobectomy (table 6). All three differe nces were statistically significant (p<0.000l). (From the 1980s to the 1990s, the rate of permanent hypocalcemia following total thyroidectomy fell from 27.4 to 6.4%, and we used the latter figure for our compariso n.)
Laryngeal dysfunction. We found no significant differences in the rates of recurrent laryngeal dysfunction among those who underwent total thyroidectomy, subtotal thyroidectom y, and lobectom y (table 7) .
Discussion
We attempted to answer the question, Is thyroid lobectomy adequate for treating pap illary thyroid cancer in women younger than 45 years of age whose tumors are smaller than 4 em, are clinically limited to one lobe, and have not exhibited any cervical or distant metastasis or other extrathyroidal spread (T2NOMO) ? We conclude that it is. Both mortality and recurrence rates were low in this group of patients. The case for total thyroidectomy. Authors have proposed many reasons why total thyroidectomy should be perform ed as a treatment for differentiated thyroid carcinoma:
• Patients with clinically unilateral papillary malignancies have high rates of "multicentricity" and microscopic cancer in the opposite lobe.8.1 6.26
• Radioactive iodine scanning can be used to diagnose and treat any residual thyroid carcinoma and metastasis.
• Total thyroidectomy lowers the risk of recurrence.v'F" • Serum thyrogl obulin levels can be measured durin g follow-up to screen for recurrent or metastatic disease in patients with well-differe ntiated cancer.
• Total thyroidectomy carries a low risk of causing hypoparathyroidism and recurrent laryngeal nerve injury."
• The administration of high-dose radioactive iodine to ablate normal thyroid remnants can lead to sialadenitis, pulmonary fibrosis ; and leukemia."
• Total thyroidectomy eliminates the possibility of anaplastic transform ation of the residual thyroid gland."
• Total thyroidectomy alleviates patient anxiety, particularly with respect to recurrence and the need for additional surgery .
Th e case again st total thyroidectomy. Other authors have challenge d the appropriateness of total thyroidectomy for several reasons :
• The risk of permanent hypoparathyroidism can lead to fatigue, paresthesias, and irritabil ity."
• At best, contralateral recurrent laryngeal nerve damage can result in a breathy voice (unilateral recurrent laryngeal dysfunction); at worst, it can lead to airway obstruction (bilateral recurrent laryngeal nerve dysfunction).
• Among patients who undergo lobectomy for grossly unilateral papillary carcino ma, there is a lack of evidence that the high incidence of microscopic foci in the opposite lobe increases the risk of clinical recurrence." Tollefsen et al reported that in papillary cancer, the rate of occult carcinoma in the contralateral lobe was 38%,29a rate eight times greater than the incidence of clinically recurrent carcinoma in the opposite lobe follow ing initial lobectomy. This finding suggests that the presence of microscopic foci in differentiated thyroid cancer does not mean development of clinically significant cancer.
• When all macroscopic disease has been removed during initial lobectomy, the need for remnant resection of recurrence is infrequent. 30 • In young patients with papillary carci noma of the thyroid, most cases of recurrence are attributable to re- Table 5 
. Mortality and recurrence according to the type of operation (total thyroidectomy [TTl vs subtotal thyroidectomy or lobectomy [5TILl)
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Total

PROGNOSTIC FACTORS IN MORTALITY AND MO RBIDITY IN PATIENTS WIT H DIFFERENTIATED THYROI D CANCER
gional lymph node flare-ups. Even dela yed resection is not associated with an increa se in the risk of death in these patients, a fact illu strated by the lack of mortality associated with palpable lymph nod e metastase s, either at the initial evaluation or during follow-up ."
• The risk of toxicity from ablative radioiodine is low. " • Anaplastic transformation of papillary thyroid carcinoma is rare (1/17,000 patients)."
• Man y patients are classified as members of clinically low-risk groups that have high survival rates.
Predictingoutcomes. Many scoring systems have been devised in an effort to predict outcomes based on patient and tumor characteristics other than age alone :
• Hay et al wrote that the four mos t important prognostic factors are age , tumor grade, extrathyroidal extension, and tumor size (AGES).lO • Cady and Rossi found that grade is difficult to classify because of variations in pathologic interpretations, and they suggested an alternative to AGES : age, distant metastasis, extrathyroidal extension, and tumor size (AMES). 12 • Other scoring systems include the Ohio State University classification," the EORTC (European Organisation for Research and Treatment of Cancer) system," the agerelated TNM system," the MA CIS (me tastasis, age, completeness of resection, invasion, and size) classification from the Mayo Clinic," the clinical class syst em devised by DeGroot et al," the MSK (Memorial Sloan-Ke tterin g) Win, MC NAMARA system," the Noguchi system from Japan," and the SAG (size, age, grade) system from Norw ay." The use of so many varied classification systems complicates the proce ss of data comparison. The adoption of a uniform system would accelerate our under standing of prognostic factors.
The choice of surgical procedure. The decision as to which type of surgery to perform is sometimes clear and sometimes not:
• Total thyroidectomy is nearly univer sally recommended for high-risk patients.
• Thyroid lobectomy, the least drastic surgical alternative for treating differentiated thyroid malignancy, is a well-accepted choice for low-risk patients-that is, younger patients « 45 yr) whose tumors are smaller than I cm (Tl NOMO). Among these low-ri sk patient s, both Hay et al 40 and Mazzaferri" found that there was little difference in mort ality rates between those who underwent total thyroidectom y and those who underw ent lobectomy.
• There is no clear-cut choice for patients who are younger than 45 years who have tumors that are grossly limited to one lobe and between I and 4 em in size (T2NOMO) and who have experienced no cervic al or distant metastasis or extrathyroidal spread.
• Partial thyroidectomy for any type of thyroid cancer should not be considered."
Recurrence. Repo rted data on the risk of recurrence following lobectomy and total thyroidectomy are conflicting. Hay et al 40 and Mazzaferri" reported that lowrisk patients who underwent total thyroidectomy had lower recurrence rates than did those who underwent lobectomy . However, Shaha et aF2and Sanders and Cady? found no significant difference in recurrence rates among low-risk patients. Hay et al 40 and Sanders and Cady" reached conflicting conclu sions despite the fact that they used the same classification system (AMES).
In conclu sion, women younger than 45 years who have a papillary thyroid cancer smaller than 4 ern that is limited clinically to one lobe and who have no nodal or distant metastasis or other extrathyroidal spread are considered to be at low risk for mortality and morbidity with thyroid lobectomy. Total thyroidectomy, in the hands of an experienced surgeon whose postsurgical rates of hypocalcemia and recurrent laryngeal nerve paralysis are low, provides women with T2NOMO papill ary thyroid cancer a potentially lower incidence of recurrence. An unambiguou s advantage of total thyroidectom y is that it allows for precise follow-up with thyroglobulin and radioacti ve iodine scanning. Every patient' s case is unique , of course, so therapeutic decisions should be made in consultation with the patient' s endocrinologist, internist, or family physician. 862 THE VOICE FOUNDATION'S 32 nd Annual Symposium: Care of the Professional Voice June 4 -8, 2003 The Doubletree Hotel Philadelphia, Pennsylvania Robert Th ayer Sataloff, M.D., D.M .A. Chairman
The specialty of voice care involves rapidly advancing technology, new medical and scientific knowledge, and constant advancement in patient care. For thirty-two years, The Voice Foundation's Annual Symposium has been the premier international meeting designed to fulfill the need for interdisciplinary communication and education. Come and hear presentations given by scientists, physicians, speech-language pathologists, singers, singing teachers, and more of the world 's leading experts in the care of the professional voice.
For further information, call or write :
The Voice Foundation You can earn 36 hours of category 1 Continuing Medical Education (CME) credits each year, simply by successfully completing the CME test that appears monthly in EAR NOSE & THROAT JOURNAL. The cost is modest-only $ 10 per credit-and what could be more convenient than earning CME credits from the comfort of your own home or office?
When your copy of ENT JOURNAL arrives each month , simply locate the CME test in the table of contents and then answer the multiple choice questions on the answer sheet supplied at the end of the test. Return the completed answer sheet with payment for your registration fee. If you receive a passing grade, you will be sent documentation of the credits received.
For more information on the CME program contact:
Brenda Ram, CMP University of Nebraska Medical Center Center for Continuing Education 986800 Nebraska Medical Center Omaha, NE 68198-6800 Telephone: (402) 559-4152; fax: (402) 559-5915
